Genmab - 51 Year Dividend History | GMAB

Historical dividend payout and yield for Genmab (GMAB) since 1971. The current TTM dividend payout for Genmab (GMAB) as of January 20, 2022 is $0.00. The current dividend yield for Genmab as of January 20, 2022 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $22.837B $1.549B
Genmab A/S is a biotechnology company. It specializes in development of antibody therapeutics for the treatment of cancer. The company's product pipeline includes DARZALEX(R), Arzerra(R), tisotumab vedotin, enapotamab vedotin, HexaBody-DR5/DR5(R) and DuoBody-CD3xCD20 (R),which are in clinical stage. Genmab A/S is based in Copenhagen V, Denmark.
Stock Name Country Market Cap PE Ratio